Metformin and Dapagliflozin Attenuate Doxorubicin-Induced Acute Cardiotoxicity in Wistar Rats: An Electrocardiographic, Biochemical, and Histopathological Approach

Doxorubicin is a widely used anticancer drug whose efficacy is limited due to its cardiotoxicity. There is no ideal cardioprotection available against doxorubicin-induced cardiotoxicity. This study aimed to investigate the anticipated cardioprotective potential of metformin and dapagliflozin against...

Descripción completa

Detalles Bibliográficos
Autores principales: Satyam, Shakta Mani, Bairy, Laxminarayana Kurady, Shetty, Prakashchandra, Sainath, P., Bharati, Sanjay, Ahmed, Akheruz Zaman, Singh, Varun Kumar, Ashwal, A. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950216/
https://www.ncbi.nlm.nih.gov/pubmed/36790727
http://dx.doi.org/10.1007/s12012-023-09784-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950216/
https://www.ncbi.nlm.nih.gov/pubmed/36790727
http://dx.doi.org/10.1007/s12012-023-09784-8

Ejemplares similares